These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

754 related articles for article (PubMed ID: 21258649)

  • 1. Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases.
    Martin LJ
    Pharmaceuticals (Basel); 2010; 3(4):839-915. PubMed ID: 21258649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biology of mitochondria in neurodegenerative diseases.
    Martin LJ
    Prog Mol Biol Transl Sci; 2012; 107():355-415. PubMed ID: 22482456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial pathobiology in Parkinson's disease and amyotrophic lateral sclerosis.
    Martin LJ
    J Alzheimers Dis; 2010; 20 Suppl 2():S335-56. PubMed ID: 20413846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial pathobiology in ALS.
    Martin LJ
    J Bioenerg Biomembr; 2011 Dec; 43(6):569-79. PubMed ID: 22083126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondriopathy in Parkinson disease and amyotrophic lateral sclerosis.
    Martin LJ
    J Neuropathol Exp Neurol; 2006 Dec; 65(12):1103-10. PubMed ID: 17146283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mitochondrial permeability transition pore: a molecular target for amyotrophic lateral sclerosis therapy.
    Martin LJ
    Biochim Biophys Acta; 2010 Jan; 1802(1):186-97. PubMed ID: 19651206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases.
    Mattson MP; Pedersen WA; Duan W; Culmsee C; Camandola S
    Ann N Y Acad Sci; 1999; 893():154-75. PubMed ID: 10672236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic mice with human mutant genes causing Parkinson's disease and amyotrophic lateral sclerosis provide common insight into mechanisms of motor neuron selective vulnerability to degeneration.
    Martin LJ
    Rev Neurosci; 2007; 18(2):115-36. PubMed ID: 17593875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress, mitochondrial damage and neurodegenerative diseases.
    Guo C; Sun L; Chen X; Zhang D
    Neural Regen Res; 2013 Jul; 8(21):2003-14. PubMed ID: 25206509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Insight into the Molecular Mechanism of Mitochondrial Toxicant-induced Neuronal Apoptosis in Parkinson's Disease.
    Brahadeeswaran S; Lateef M; Calivarathan L
    Curr Mol Med; 2023; 23(1):63-75. PubMed ID: 35125081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodegenerative diseases and oxidative stress.
    Emerit J; Edeas M; Bricaire F
    Biomed Pharmacother; 2004 Jan; 58(1):39-46. PubMed ID: 14739060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy and apoptosis dysfunction in neurodegenerative disorders.
    Ghavami S; Shojaei S; Yeganeh B; Ande SR; Jangamreddy JR; Mehrpour M; Christoffersson J; Chaabane W; Moghadam AR; Kashani HH; Hashemi M; Owji AA; Łos MJ
    Prog Neurobiol; 2014 Jan; 112():24-49. PubMed ID: 24211851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
    Hashimoto M; Rockenstein E; Crews L; Masliah E
    Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria, oxidative stress and neurodegeneration.
    Federico A; Cardaioli E; Da Pozzo P; Formichi P; Gallus GN; Radi E
    J Neurol Sci; 2012 Nov; 322(1-2):254-62. PubMed ID: 22669122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.
    Konovalova J; Gerasymchuk D; Parkkinen I; Chmielarz P; Domanskyi A
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders.
    Islam MT
    Neurol Res; 2017 Jan; 39(1):73-82. PubMed ID: 27809706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases.
    Reddy PH; Reddy TP; Manczak M; Calkins MJ; Shirendeb U; Mao P
    Brain Res Rev; 2011 Jun; 67(1-2):103-18. PubMed ID: 21145355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration.
    Cassarino DS; Bennett JP
    Brain Res Brain Res Rev; 1999 Jan; 29(1):1-25. PubMed ID: 9974149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.